ScholarIQanswers from OpenAlex & ORCID
Jean‐Luc Raoul
ResearcherPublications, citations & collaboration network
Jean‐Luc Raoul is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Jean‐Luc Raoul have?
ScholarIQindexed works
Jean‐Luc Raoul has 504 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Jean‐Luc Raoul have?
ScholarIQcitation count
Jean‐Luc Raoul has 59,728 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Jean‐Luc Raoul?
ScholarIQh-index
Jean‐Luc Raoul has an h-index of 71 in OpenAlex.
What is the i10-index of Jean‐Luc Raoul?
ScholarIQi10-index
Jean‐Luc Raoul has an i10-index of 219 in OpenAlex.
What is the ORCID of Jean‐Luc Raoul?
ScholarIQorcid
The ORCID for Jean‐Luc Raoul is on the source record.
What is the OpenAlex record for Jean‐Luc Raoul?
ScholarIQopenalex
The OpenAlex for Jean‐Luc Raoul is on the source record.
What are the most-cited papers on Jean‐Luc Raoul?
ScholarIQmost cited works
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
Éric Raymond, Laëtitia Dahan, Jean‐Luc Raoul, Yung‐Jue Bang, Ivan Borbath, Catherine Lombard‐Bohas, Juan W. Valle, Peter Metrakos, Denis Smith, Aaron I. Vinik, Jen‐Shi Chen, Dieter Hörsch, Pascal Hammel, Bertram Wiedenmann, Eric Van Cutsem, Shem Patyna, Dongrui R. Lu, C. Blanckmeister, Richard C. Chao, Philippe Ruszniewski
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial
Valérie Vilgrain, Héléna Pereira, Eric Assenat, Boris Guiu, Alina Diana Ilonca, Georges-Philippe Pageaux, Annie Sibert, Mohamed Bouattour, Rachida Lebtahi, Wassim Allaham, Hélène Barraud, Valérie Laurent, E. Mathias, Jean-Pierre Bronowicki, J.P. Tasu, R. Perdrisot, Christine Silvain, René Gerolami, O. Mundler, Jean‐François Seitz, Vincent Vidal, Christophe Aubé, Frédéric Oberti, Olivier Couturier, Isabelle Brenot-Rossi, Jean‐Luc Raoul, Anthony Sarran, Charlotte Costentin, Emmanuel Itti, Alain Luciani, René Adam, M. Lewin, Didier Samuel, Maxime Ronot, Aurélia Dinut, Laurent Castéra, Gilles Châtellier, Eric Assenat, Elisabeth Delhom - Christol, Boris Guiu, Alina Diana Ilonca, J. Lonjon, Georges-Philippe Pageaux, Mohamed Abdel‐Rehim, Wassim Allaham, Mohamed Bouattour, Laurent Castéra, Arnaud Dieudonné, Rachida Lebtahi, Maxime Ronot, Annie Sibert, Valérie Vilgrain, Hélène Barraud, Christophe Bazin, Jean-Pierre Bronowicki, Valérie Laurent, E. Mathias, Carine Chagneau-Derrode, R. Perdrisot, Christine Silvain, J.P. Tasu, Patrick Borentain, René Gerolami, O. Mundler, Jean‐François Seitz, Vincent Vidal, Christophe Aubé, Antoine Bouvier, Olivier Couturier, Frédéric Oberti, Laurent Vervueren, Isabelle Brenot-Rossi, Jean‐Luc Raoul, Anthony Sarran, Julia Chalaye, Charlotte Costentin, Emmanuel Itti, Hicham Kobeiter, Alain Luciani, René Adam, M. Lewin, Didier Samuel, Julien Edeline, Étienne Garin, Yan Rolland, Isabelle Archambeaud, Thomas Eugène, Éric Frampas, Christophe Cassinotto, Martine Guyot, Jean‐Baptiste Hiriart, Bruno Lapuyade, Julien Vergniol, Philippe Bachellier, Julien Détour, Bernard Duclos, Michel Greget, François Habersetzer, Alessio Impériale, Philippe Merle
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
Philip J. Johnson, Shukui Qin, Joong‐Won Park, Ronnie T.P. Poon, Jean‐Luc Raoul, Philip A. Philip, Chih‐Hung Hsu, Tsung‐Hui Hu, Jeong Heo, Jianming Xu, Ligong Lu, Yee Chao, Éveline Boucher, Kwang‐Hyub Han, Seung Woon Paik, Jorge Alberto Robles-Aviña, Masatoshi Kudo, Lünan Yan, Abhasnee Sobhonslidsuk, Д. В. Комов, Thomas Decaens, Won Young Tak, Long‐Bin Jeng, David Liu, Rana Ezzeddine, Ian Walters, Ann‐Lii Cheng